Risk factors for early readmission to acute care for persons with Schizophrenia taking antipsychotic medications

Psychiatric Services

Volumn 64, Issue 12, 2013, Pages 1225-1229

  Boaz, Timothy L ^a   Becker, Marion Ann ^a   Andel, Ross ^a,b   Van Dorn, Richard A ^c   Choi, Jiyoon ^d   Sikirica, Mirko ^e  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b ST ANNE S UNIVERSITY HOSPITAL   (Czech Republic)

^c RTI INTERNATIONAL   (United States)

^d JANSSEN RESEARCH AND DEVELOPMENT   (United States)

^e BAYER PHARMA AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

FLUPHENAZINE; HALOPERIDOL; NEUROLEPTIC AGENT; RISPERIDONE;

ADULT; ARTICLE; COMORBIDITY; EMERGENCY CARE; FEMALE; HEALTH CARE; HOSPITAL PATIENT; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MENTAL HOSPITAL; MENTAL PATIENT; RISK FACTOR; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; FEMALE; FLORIDA; HUMANS; LENGTH OF STAY; MALE; MEDICAID; MIDDLE AGED; PATIENT ADMISSION; PATIENT READMISSION; RISK FACTORS; SCHIZOPHRENIA; UNITED STATES;

EID: 84888872452     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.003382012     Document Type: Article

References (22)

1. Durbin J, Lin E, Layne C, et al: Is readmission a valid indicator of the quality of inpatient psychiatric care? Journal of Behavioral Health Services and Research 34:137-150, 2007
2. Schmutte T, Dunn CL, Sledge WH: Predicting time to readmission in patients with recent histories of recurrent psychiatric hospitalization: a matched-control survival analysis. Journal of Nervous and Mental Disease 198:860-863, 2010
3. Benbassat J, Taragin M: Hospital readmissions as a measure of quality of health care: advantages and limitations. Archives of Internal Medicine 160:1074-1081, 2000
4. Feigenbaum P, Neuwirth E, Trowbridge L, et al: Factors contributing to all-cause 30-day readmissions: a structured case series across 18 hospitals. Medical Care 50:599-605, 2012
5. Jencks SF, Williams MV, Coleman EA: Rehospitalizations among patients in the Medicare fee-for-service program. New England Journal of Medicine 360:1418-1428, 2009
6. Askren-Gonzalez A, Frater J: Case management programs for hospital readmission prevention. Professional Case Management 17:219-226, quiz 227-228, 2012
7. Weiden PJ, Olfson M: Cost of relapse in schizophrenia. Schizophrenia Bulletin 21:419-429, 1995
8. Schennach R, Obermeier M, Meyer S, et al: Predictors of relapse in the year after hospital discharge among patients with schizophrenia. Psychiatric Services 63:87-90, 2012
9. Valenstein M, Copeland LA, Blow FC, et al: Pharmacy data identify poorly adherent patients with schizophrenia at increased risk for admission. Medical Care 40:630-639, 2002
10. Weiden PJ, Kozma C, Grogg A, et al: Partial compliance and risk of rehospitalization among California Medicaid patients with schizophrenia. Psychiatric Services 55:886-891, 2004
11. Schmutte T, Dunn C, Sledge W: Characteristics of inpatients with a history of recurrent psychiatric hospitalizations: a matched-control study. Psychiatric Services 60:1683-1685, 2009
12. Figueroa R, Harman J, Engberg J: Use of claims data to examine the impact of length of inpatient psychiatric stay on readmission rate. Psychiatric Services 55:560-565, 2004
13. Maples NJ, Copeland LA, Zeber JE, et al: Can medication management coordinators help improve continuity of care after psychiatric hospitalization? Psychiatric Services 63:554-560, 2012
14. Kim YJ, Soeken KL: A meta-analysis of the effect of hospital-based case management on hospital length-of-stay and readmission. Nursing Research 54:255-264, 2005
15. Prince JD: Practices preventing rehospitalization of individuals with schizophrenia. Journal of Nervous and Mental Disease 194:397-403, 2006
16. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 40:373-383, 1987
17. Williams RL: A note on robust variance estimation for cluster-correlated data. Biometrics 56:645-646, 2000
18. Druss BG, Mauer BJ: Health care reform and care at the behavioral health - primary care interface. Psychiatric Services 61:1087-1092, 2010
19. Druss BG, Walker ER: Mental Disorders and Medical Comorbidity. Princeton, NJ, Synthesis Project, 2011. Available at www.rwjf.org/content/dam/farm/ reports/issue-briefs/2011/rwjf69438/subassets/rwjf69438-1
20. Flynn PM, Brown BS: Co-occurring disorders in substance abuse treatment: issues and prospects. Journal of Substance Abuse Treatment 34:36-47, 2008
21. Drake RE, Mueser KT, Brunette MF, et al: A review of treatments for people with severe mental illnesses and co-occurring substance use disorders. Psychiatric Rehabilitation Journal 27:360-374, 2004
22. Appleby L, Luchins DJ, Desai PN, et al: Length of inpatient stay and recidivism among patients with schizophrenia. Psychiatric Services 47:985-990, 1996